KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) FCF Margin (2016 - 2025)

Charles River Laboratories International has reported FCF Margin over the past 17 years, most recently at 5.89% for Q4 2025.

  • Quarterly results put FCF Margin at 5.89% for Q4 2025, down 246.0% from a year ago — trailing twelve months through Dec 2025 was 12.91% (up 53.0% YoY), and the annual figure for FY2025 was 12.91%, up 53.0%.
  • FCF Margin for Q4 2025 was 5.89% at Charles River Laboratories International, down from 17.74% in the prior quarter.
  • Over the last five years, FCF Margin for CRL hit a ceiling of 21.1% in Q3 2024 and a floor of 0.24% in Q2 2023.
  • Median FCF Margin over the past 5 years was 13.28% (2021), compared with a mean of 11.27%.
  • Biggest five-year swings in FCF Margin: soared 1118bps in 2021 and later plummeted -1482bps in 2022.
  • Charles River Laboratories International's FCF Margin stood at 14.42% in 2021, then dropped by -8bps to 13.25% in 2022, then grew by 6bps to 14.07% in 2023, then plummeted by -41bps to 8.35% in 2024, then fell by -29bps to 5.89% in 2025.
  • The last three reported values for FCF Margin were 5.89% (Q4 2025), 17.74% (Q3 2025), and 16.4% (Q2 2025) per Business Quant data.